Placenta Market Projected to Reach USD 1,404.87 Million by 2034

The global Placenta market was valued at USD 599.45 million in 2024, and it is projected to grow to USD 1,404.87 million by 2034. During the forecast period from 2025-2034, the market is estimated to rise at a compound annual growth rate (CAGR) of 8.9%. This upward trajectory is largely fueled by The placenta, an organ that forms during pregnancy to deliver oxygen and nutrients to the developing fetus, has garnered substantial interest in both the medical and cosmetic industries. Placenta-derived products are widely utilized in anti-aging skincare, thanks to their rich content of bioactive compounds that promote skin rejuvenation, improve elasticity, and reduce the appearance of wrinkles.

Market Definition

Involves the development and supply of electrical substations that regulate voltage and distribute electricity from power plants to end users.

Key Report Highlights

· The report highlights the key region that accounts for the highest revenue share in the global Placenta market.

· It identifies the leading country within this region that makes a significant contribution to the market’s overall performance.

· The report outlines the dominant segment that holds a major share of the market.

· It also emphasizes the fastest-growing segment projected to gain strong traction during the forecast period.

· Qualitative and quantitative market analysis have been used to provide an in-depth understanding of the market.

Market Overview: Key Figures at a Glance

· Market Value in [2024]: USD 599.45 million

· Projected Market Size in [2034]: USD 1,404.87 million

· Anticipated CAGR (2034): 8.9%

Get access to the full report or request a complimentary sample for in-depth analysis: https://www.polarismarketresearch.com/industry-analysis/placenta-market/request-for-sample

Market Growth Drivers

Placenta-derived biologics are increasingly used in regenerative medicine and wound healing, especially for chronic wounds, burns, and orthopedic conditions. Products like amniotic membranes, placental stem cells, and extracellular matrix components accelerate tissue repair, reduce inflammation, and boost angiogenesis. With the rising prevalence of diabetic foot ulcers, venous leg ulcers, and pressure ulcers, demand for advanced placental allografts is growing. Widely adopted products such as EpiFix, Affinity, and AmnioBand promote faster healing and lower infection risks, leading hospitals and clinics to integrate them into standard care—driving placenta market growth.

Market Key Players

The competitive landscape features a mix of long-standing companies and emerging contenders. Leading players are actively pursuing R&D initiatives and strategic moves to strengthen their market position. Notable participants include